Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)
Close on Nov 17, 2026Market cap $140.36MP/E –Yield –
Drugs Made In America Acquisition II total assets
Total assets on the balance sheet at the end of each period.
Drugs Made In America Acquisition II's total assets was $518.72M at Sep 30, 2026. For fiscal 2025 it was $504.96M, up 365643.3% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $504.96M | +365643.3% |
| FY2024 | Dec 31, 2024 | $138.06K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $518.72M | +3.5% |
| Q2 FY2026 | Jun 30, 2026 | $514.10M | +372263.7% |
| Q1 FY2026 | Mar 31, 2026 | $509.73M | – |
| Q4 FY2025 | Dec 31, 2025 | $504.96M | – |
| Q3 FY2025 | Sep 30, 2025 | $501.01M | – |
| Q4 FY2024 | Dec 31, 2024 | $138.06K | – |
See a number that looks wrong?